India Thyroid Function Test Market

India Thyroid Function Test Market Size, Market Forecast and Outlook By FMI

The india thyroid function test market stood at USD 55.3 million in 2025 and is projected to reach USD 97.2 million by 2035. The market is projected to register a 5.8% during the forecast period. The revenue generated by thyroid function testing in 2024 was USD 52.9 million. TSH testing is projected to expand at approximately 6.12% CAGR during the forecast period.

Summary of the India Thyroid Function Test Market

• Demand and Expansion Drivers
  • Patient access and diagnosis growth support use across care settings.
  • Clinical workflow needs raise demand for reliable products and services.
  • Specialist care expansion improves treatment and testing availability.
  • Provider focus on safety and outcomes supports product evaluation.
• Product and Segment View
  • Leading product categories support routine clinical use and repeat demand.
  • Specialist applications improve value across higher-acuity care settings.
  • Hospital and clinic use remains central to product adoption.
  • Service support improves provider confidence across care pathways.
• Geography and Competitive Outlook
  • North America remains important through specialist access and reimbursement.
  • Europe supports demand through mature healthcare infrastructure.
  • Asia Pacific expands through hospital capacity and diagnosis growth.
  • Companies with clinical evidence and provider training hold stronger positions.
• Analyst Opinion
  • Sabyasachi Ghosh, Principal Consultant at FMI states: ""India Thyroid Function Test demand is shaped by clinical need and provider access. Leading categories remain central because care pathways need reliable products and consistent outcomes. Hospitals and specialist settings influence adoption across daily practice. Product quality and training support affect provider confidence. Companies with evidence and service strength can improve market position.""
• India Thyroid Function Test Market Value Analysis
  • Clinical use creates value through recurring treatment and testing needs.
  • Hospital adoption supports premium demand and service contracts.
  • Specialist settings improve product utilization across targeted care pathways.
  • Training and evidence strengthen provider preference.

India Thyroid Function Test Industry Assessment

Attributes	Key Insights
Estimated Size, 2025	USD 55.3 million
Projected Size, 2035	USD 97.2 million
Value-based CAGR (2025 to 2035)	5.8%

General Population Prevalence of Thyroid in India

Thyroid disorders show a rising trend in the general population based on national health surveys, underscoring growing awareness and diagnosis rates.

• NFHS‑5 (2019-21) recorded 2.9% of the population self‑reporting a goitre or thyroid disorder, up from 2.2% in NFHS‑4 (2015-16).
• Government summaries and the NFHS dataset confirm the steady increase in reported cases, reflecting both disease burden and broader detection.

Biochemically Confirmed Hypothyroidism in Adults

Urban adult studies highlight a significant burden, with marked gender differences and a high rate of subclinical cases.

• An eight‑city cross‑sectional study found 10.95% overall hypothyroidism prevalence, with 15.86% in females and 5.02% in males.
• Subclinical hypothyroidism accounted for 8.02% of cases, while anti‑TPO antibody positivity reached 21.85%, pointing to substantial autoimmune contribution.

Thyroid Disorders in Pregnancy and Newborns

Pregnant women and newborns represent high‑risk populations, with prevalence exceeding that seen in many other regions globally.

• A meta‑analysis covering 61 studies (n = 60,066) showed 11.07% overall hypothyroidism in pregnancy (95% CI 8.79-13.84), with 9.51% subclinical and 2.74% overt cases.

Congenital hypothyroidism affects about 1 in 1,000 live births in India (0.97 per 1,000), a rate far higher than the 1:3,000 to 1:4,000 observed in many other countries.

Semi Annual Market Update

The below table presents the expected CAGR for the India thyroid function test market over several semi-annual periods spanning from 2025 to 2035. In the first half (H1) of the decade from 2024 to 2035, the business is predicted to surge at a CAGR of 6.8%, followed by a slightly lower growth rate of 6.4% in the second half (H2) of the same decade.

Particular	Value CAGR
H1 (2024 to 2035)	6.8%
H2 (2024 to 2035)	6.4%
H1 (2025 to 2035)	5.8%
H2 (2025 to 2035)	5.5%

Moving into the subsequent period, from H1 2025 to H2 2035, the CAGR is projected to decrease slightly to 5.8% in the first half and decrease moderately at 5.5% in the second half. In the first half (H1) the market witnessed an increase of 100.00 BPS while in the second half (H2), the market witnessed a decrease of 90.00 BPS.

Key Industry Highlights

The Increasing Prevalence of Thyroid Disorders Is a Significant Driver Propelling the Market Growth.

The increasing prevalence of thyroid disorders, including hypothyroidism, hyperthyroidism, and thyroid nodules, is a significant driver propelling the growth of the thyroid function test market in India. The growing burden of thyroid diseases combined with increased awareness and greater patient access to healthcare has resulted in higher demand for available distantly located diagnostics tests in this region.

Growing burden of thyroid diseases combined with the limited number of healthcare providers and equipment available would result in high demand for the available distantly-located diagnostic services in this region.

The main reasons for increased thyroid problems include iodine deficiency, which really remains a concern in areas where diets lack proper iodine intake. Autoimmune diseases like Hashimoto's thyroiditis along with Graves' disease also occur more often, which adds to the affected population. Modern lifestyle factors such as poor diet habits, high stress levels as well as inactive daily routines contribute to hormone imbalances that make people more likely to develop thyroid problems.

A larger patient base has, therefore been calling for faster and more reliable diagnostic results. Detection and tracking of thyroid illnesses early is central to proper control of the diseases. As such, the current use of many tests that determine T3, T4, and TSH levels are inevitable as they help one establish the state of abnormality and consequently the treatments needed. Their importance is greater among the more susceptible populations.

This increasing burden of thyroid disorders makes efficient diagnostic solutions more pressing, thereby acting as an important driving factor for the thyroid function test market in India.

Advancements in Immunoassay Techniques Driving the India Thyroid Function Test Market

Latest advancements in testing relating to thyroid are taking place in India thanks to the novel methods such as chemiluminescent immunoassays and enzyme-linked immunosorbent assays. These are highly efficient in detecting thyroid hormones such as T3, T4, and thyroid-stimulating hormone (TSH) with great precision. Knowing the state of severe symptoms would be of great importance in detecting thyroid-related issues, which may seriously affect health without any specific symptoms.

Chemiluminescent immunoassay (CLIA) is considered a favorite since it conducts numerous samples accurately and rapidly while providing very reliable results. ELISA is inexpensive and gives expected results hence can be used in city clinics and even rural health centers.

With more sophisticated testing techniques to detect thyroid disorders at an earlier stage, doctors start treatment immediately to prevent the occurence of fatal consequences from untreated thyroid conditions and complications. The use of modern automated testing equipment has accelerated the speed of the procedures thereby improving patient care.

More and more hospitals and laboratories in India are implementing such advanced techniques into their facilities as routine. The thyroid testing market is enlarging by all this referred modernization due to the huge demands for tests which are accurate but at the same time fast and available to all, no matter where they live.

Government and Private Sector Initiatives Driving the India Thyroid Function Test Market

The Indian government as well as private sector have always played a pioneering role in advancing the diagnostic structure, which has provided a boost in the growth process of the market for thyroid function testing. Healthcare support policies, subsidies as well as strategically planned collaborations facilitate access to and enhance diagnostic health services in difficult and remote inaccessible areas.

Initiatives such as the National Health Mission (NHM) are implemented by the government to expand diagnostic facilities in rural areas, meeting the healthcare needs of populations susceptible to thyroid disorders. Subsidized testing programs and awareness campaigns have increased public knowledge about thyroid health, which encourages early diagnosis and treatment.

PPPs supplement these efforts, as they involve private players bringing their resources and expertise to expand the reach and quality of diagnostic services.

Private healthcare companies and diagnostic businesses are crucial in driving innovation and improving facilities. They are investing in advanced tools, such as automated machines for immune response tests and devices that allow for on-site health testing. These improvements make thyroid function tests quicker and more accurate. Moreover, these companies are growing their operations in tier-2 and tier-3 cities, which helps reduce the healthcare gap between urban and rural areas.

Economic Constraints of the Target Population Impacting the India Thyroid Function Test Market

Financial challenges are a major obstacle to the growth of the thyroid function test market in India. Many people in low-income and rural areas cannot afford regular thyroid testing. Due to limited financial resources, they often focus on immediate health needs rather than on preventive or diagnostic tests, which can result in late or missed diagnoses of thyroid disorders.

Government efforts to make healthcare more affordable frequently fall short of addressing financial disparities across different demographics. High out-of-pocket healthcare expenses in India further discourage routine thyroid testing, particularly in areas without adequate health insurance coverage.

The costs associated with advanced diagnostic technologies, like chemiluminescent immunoassays (CLIA) and automated analyzers, make thyroid tests less accessible to poorer populations. Although more affordable point-of-care (POC) devices and mobile health units are available, their adoption is limited due to infrastructure problems and uneven distribution across regions.

These financial barriers emphasize the necessity for targeted strategies to improve access and foster market growth. Potential solutions include expanding insurance coverage, enhancing public-private partnerships, and promoting low-cost diagnostic alternatives to ensure broader access to thyroid function tests.

2020 to 2024 India Thyroid Function Test Sales Outlook Compared to Demand Forecast from 2025 to 2035

The India thyroid function test industry recorded a CAGR of 4.3% during the historical period between 2020 and 2024. The growth of thyroid function test industry was positive as it reached a value of USD 52.9 million in 2024 from USD 50.6 million in 2020.

The India thyroid function test market has grown extensively over the years due to a rapidly increasing number of patients affected with thyroid diseases, increased awareness about the diagnosis and treatment, and advancements in the diagnostic techniques.

Traditionally, thyroid function tests were performed mostly in bigger cities, and access in the rural sector was limited mainly because of lack of infrastructure and cost. However, the market has been revolutionized by the adoption of advanced diagnostic tools, including immunoassay technologies and point-of-care testing devices, which have improved accessibility, speed, and accuracy of testing even in remote areas.

The market is growing steadily, due to the efforts of the government and the private sectors, in the form of improvement in health infrastructure, free testing services, and raising awareness about thyroid health. Integration of cost-effective diagnostic solutions and telemedicine has further contributed toward the expansion of market growth.

Going forward, the market is set to increase because of continued advancements in diagnostic technologies, expanded adoption of AI and automation in laboratories, and increased accessibility of healthcare services in rural regions.

Personalized medicine with a better approach to treating thyroid disorders is also going to play a role in the development and usage of tests. In addition, the increasing adoption of POC testing and integration with digital health platforms will redefine patient care models and fuel market growth in the coming years.

Market Concentration

Tier 1 companies comprise market leaders with a significant market share of 49.3% in India market. These companies engage in strategic partnerships and acquisitions to expand their product portfolios and access cutting-edge technologies.

Additionally, they emphasize extensive clinical trials to validate the efficacy and safety of their products. Prominent companies in tier 1 include Thyrocare Technologies Ltd., Dr. Lal PathLabs, Metropolis Healthcare Ltd. and SRL Diagnostics

Tier 2 companies include mid-size players having presence in specific regions and highly influencing the local market and holds around 21.7% market share. They typically pursue partnerships with multispecialty hospitals and research organizations to leverage emerging technologies and expedite product development.

These companies often emphasize agility and adaptability, allowing them to quickly bring new products to market, additionally targeting specific types medical needs. Additionally, they focus on cost-effective production methods to offer competitive pricing. Prominent companies in tier 2 include Apollo Diagnostics, Quest Diagnostics India, Suburban Diagnostics and Abbott India.

Finally, Tier 3 companies, such as FiRoche Diagnostics India and Siemens Healthineers India and others. They specialize in specific products and cater to niche markets, adding diversity to the industry.

Overall, while Tier 1 companies are the primary drivers of the market, Tier 2 and 3 companies also make significant contributions, ensuring the thyroid function test sales remains dynamic and competitive.

Category-wise Insights

By Test Type, the TSH (Thyroid Stimulating Hormone) Segment Accounts for 60.2% of the Market Share

TSH (Thyroid Stimulating Hormone) holds the dominant position with 60.2% of the market share in the test type category within the India thyroid function test market. This leadership is driven by TSH's exceptional sensitivity in identifying even mild or subclinical thyroid imbalances, making it the gold standard for evaluating thyroid function.

TSH testing is particularly significant in diagnosing hypothyroidism and hyperthyroidism, serving as the most reliable marker for assessing thyroid gland functionality.

The segment's dominance is reinforced by TSH testing's cost-effectiveness and ease of administration, making it widely accessible across both urban and rural locations throughout India.

The test can be easily incorporated into routine health check-ups, which explains its popularity among individuals seeking preventive healthcare. As awareness about thyroid disorders continues to grow and more people opt for routine thyroid function testing, TSH is increasingly being ordered as the primary thyroid marker, maintaining its preference over other thyroid tests such as T3 and T4 in the Indian healthcare system.

By End User, the Diagnostic Laboratories Segment Accounts for 46.8% of the Market Share

Diagnostic laboratories represent a significant segment with 46.8% of the market share in the end user category within the India thyroid function test market. This substantial market presence is attributed to diagnostic laboratories' specialized focus on providing comprehensive thyroid testing services with advanced analytical capabilities and high-throughput processing systems.

These facilities offer dedicated expertise in thyroid function assessment, enabling accurate and reliable test results that are crucial for proper diagnosis and treatment planning.

Competitive Landscape

The companies are using strategies to stay competitive, such as product differentiation through innovative formulations, strategic partnerships with healthcare providers for distribution. Another key strategic focus of these companies is to actively look for strategic partners to bolster their product portfolios and expand their India presence.

Recent Industry Developments in thyroid function test Market

• Thyrocare acquired 100% of Think Health Diagnostics Private Limited (“Think Health”) in February 2024, enabling your Company to enter into ECG at home services.
• In 2024, Data collected from 35,000 tests over the past six months in Delhi, India indicated that approximately 33% of patients undergoing thyroid tests received abnormal results.

Key Players of thyroid function test Market

• Thyrocare Technologies Ltd.
• Dr. Lal PathLabs
• Metropolis Healthcare Ltd.
• SRL Diagnostics
• Apollo Diagnostics
• Quest Diagnostics India
• Suburban Diagnostics
• Abbott India
• Roche Diagnostics India
• Siemens Healthineers India

Report Coverage for India Thyroid Function Test Market

Report Attributes	Details
Current Total Market Size (2025)	USD 55.3 million
Projected Market Size (2035)	USD 97.2 million
Overall Market CAGR (2025 to 2035)	5.8%
Base Year for Estimation	2024
Historical Period	2019 to 2024
Projections Period	2025 to 2035
Report Parameter	Revenue in USD million
Test Types Analyzed	TSH (Thyroid Stimulating Hormone), T3 (Tri-iodothyronine), T4 (Thyroxine), FT3 (Free Tri-iodothyronine), FT4 (Free Thyroxine).
End Users Analyzed	Clinics, Research Organizations, Diagnostic Laboratories, Hospitals.
Key Players	Thyrocare Technologies Ltd., Dr. Lal PathLabs, Metropolis Healthcare Ltd., SRL Diagnostics, Apollo Diagnostics, Quest Diagnostics India, Suburban Diagnostics, Abbott India, Roche Diagnostics India, Siemens Healthineers India.
Additional Attributes	Technological Innovations, Regulatory Compliance, Sustainability Initiatives, Market Dynamics
Customization and Pricing	Available upon request

Key Segments of thyroid function test Market

By Test Type:

• TSH (thyroid stimulating hormone)
• T3 (tri-iodothyronine)
• T4 (thyroxine)
• FT3 (free tri-iodothyronine)
• FT4 (free thyroxine)

By End User:

• Clinics
• Research organizations
• Diagnostic laboratories
• Hospitals